)
)
Renalytix Investor Relations Material
Latest events
Q3 2024
Renalytix
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Renalytix Plc
Access all reports
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company's lead product candidate is KidneyIntelX, a non-invasive blood test to predict the risk of rapid decline in kidney function, progression to kidney failure, and comorbidities related to Chronic Kidney Disease (CKD), including acute kidney injury, cardiovascular disease, and anemia.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
RNLX
Country
🇺🇸 United States